Financially Strong And High Growth Stocks

Looking to add potential meaningful upside to your portfolio, but unsure where to start? Stocks such as Alder Biopharmaceuticals and OceanFirst Financial are considered to be high growth in terms of how much they’re expected to earn and return to shareholders, according to the market. I would suggest taking a look at my list of companies that compare favourably in all criteria, and consider whether they would add value to your current portfolio.

Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR)

Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States, Australia, and Ireland. Established in 2002, and currently run by Randall Schatzman, the company size now stands at 176 people and with the company’s market cap sitting at USD $718.26M, it falls under the small-cap group.

ALDR’s projected future profit growth is a robust 26.31%, with an underlying triple-digit growth from its revenues expected over the upcoming years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. Moreover, the 29.47% growth in operating cash flows shows that a decent part of earnings is driven by robust cash generation from operational activities, not one-off or non-core activities. ALDR’s bullish prospects make it an interesting stock to invest more time to understand how it can add value to your portfolio. Interested to learn more about ALDR? Check out its fundamental factors here.

NasdaqGM:ALDR Future Profit Dec 21st 17
NasdaqGM:ALDR Future Profit Dec 21st 17

OceanFirst Financial Corp. (NASDAQ:OCFC)

OceanFirst Financial Corp. operates as the holding company for OceanFirst Bank that provides a range of community banking services to retail, government, and business customers. Established in 1902, and run by CEO Christopher Maher, the company now has 348 employees and has a market cap of USD $903.51M, putting it in the small-cap category.

An outstanding doubling of earnings is forecasted for OCFC, driven by the underlying 61.27% sales growth over the next few years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 8.64%. OCFC ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Want to know more about OCFC? Take a look at its other fundamentals here.

NasdaqGS:OCFC Future Profit Dec 21st 17
NasdaqGS:OCFC Future Profit Dec 21st 17

AmpliPhi Biosciences Corporation (AMEX:APHB)

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. Started in 1989, and currently lead by Paul Grint, the company size now stands at 33 people and with the company’s market capitalisation at USD $9.04M, we can put it in the small-cap group.

APHB’s forecasted bottom line growth is an optimistic 16.60%, driven by the underlying 70.94% sales growth over the next few years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. APHB’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Should you add APHB to your portfolio? I recommend researching its fundamentals here.

AMEX:APHB Future Profit Dec 21st 17
AMEX:APHB Future Profit Dec 21st 17

For more financially robust companies with high growth potential to enhance your portfolio, use our free platform to explore our interactive list of these stocks.